Impact of pneumococcal conjugate vaccines introduction on antibiotic resistance of Streptococcus pneumoniae meningitis in children aged 5 years or younger, Israel, 2004 to 2016

BACKGROUND: Empiric treatment of pneumococcal meningitis includes ceftriaxone with vancomycin to overcome ceftriaxone resistant disease. The addition of vancomycin bears a risk of adverse events, including increased antibiotic resistance. We assessed antibiotic resistance rates in pneumococcal menin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Euro Surveill
Autors principals: Ben-Shimol, Shalom, Givon-Lavi, Noga, Greenberg, David, Stein, Michal, Megged, Orli, Bar-Yochai, Avihu, Negari, Shahar, Dagan, Ron
Format: Artigo
Idioma:Inglês
Publicat: European Centre for Disease Prevention and Control (ECDC) 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6341944/
https://ncbi.nlm.nih.gov/pubmed/30482264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2018.23.47.1800081
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars